Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

bortezomib

  • You have access
    Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2
    VICTORIA PERRIER-TRUDOVA, BERNICE WONG HUIMIN, SARINYA KONGPETCH, DACHUAN HUANG, PAULINE ONG, AUDREY LE FORMAL, SONG LING POON, EE YAN SIEW, SWE SWE MYINT, SOPHIE GAD, BETTY GARDIE, SOPHIE COUVÉ, YU MIIN FOONG, YUKTI CHOUDHURY, JONATHAN POH, CHOON KIAT ONG, CHEE KEONG TOH, AIKSENG OOI, STÉPHANE RICHARD, MIN-HAN TAN and BIN TEAN TEH
    Anticancer Research December 2015, 35 (12) 6639-6653;
  • You have access
    Angiogenic Markers in Plasma Cell Myeloma Patients Treated with Novel Agents
    MICHAEL MEDINGER, JÖRG HALTER, DOMINIK HEIM, ANDREAS BUSER, SABINE GERULL, MARTIN STERN and JAKOB PASSWEG
    Anticancer Research February 2015, 35 (2) 1085-1090;
  • You have access
    Promise of Combining a Bcl-2 Family Inhibitor with Bortezomib or SAHA for Adult T-cell Leukemia/Lymphoma
    NAOKO KUNAMI, HIROO KATSUYA, RUMIKO NOGAMI, KENJI ISHITSUKA and KAZUO TAMURA
    Anticancer Research October 2014, 34 (10) 5287-5294;
  • You have access
    Post-transplantation Consolidation and Maintenance Therapy with Lenalidomide for Japanese Patients with Multiple Myeloma
    HIROYUKI TAKAMATSU, SAORI MUNEMOTO, RYOICHI MURATA, YASUSHI TERASAKI, KENICHI NAKAJIMA and SHINJI NAKAO
    Anticancer Research December 2013, 33 (12) 5681-5685;
  • You have access
    Daily 500 mg Valacyclovir Is Effective for Prevention of Varicella Zoster Virus Reactivation in Patients with Multiple Myeloma Treated with Bortezomib
    TOSHIHIRO FUKUSHIMA, TOMOMI SATO, TAKUJI NAKAMURA, HARUKA IWAO, AKIO NAKAJIMA, MIYUKI MIKI, TOMOYUKI SAKAI, TAKAFUMI KAWANAMI, TOSHIOKI SAWAKI, YOSHIMASA FUJITA, MASAO TANAKA, YASUFUMI MASAKI, TOSHIRO OKAZAKI, HIDEO NAKAJIMA, YOSHIHARU MOTOO and HISANORI UMEHARA
    Anticancer Research December 2012, 32 (12) 5437-5440;

Pages

  • Previous
  • 1
  • 2
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire